Snowden Capital Advisors’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-5,511
| Closed | -$215K | – | 1262 |
|
|
2024
Q2 | $215K | Buy |
5,511
+12
| +0.2% | +$468 | 0.01% | 1116 |
|
|
2024
Q1 | $237K | Sell |
5,499
-224
| -4% | -$9.64K | 0.01% | 1067 |
|
|
2023
Q4 | $264K | Sell |
5,723
-142
| -2% | -$6.54K | 0.01% | 962 |
|
|
2023
Q3 | $200K | Sell |
5,865
-131
| -2% | -$4.48K | 0.01% | 1022 |
|
|
2023
Q2 | $231K | Buy |
+5,996
| New | +$231K | 0.01% | 1051 |
|